Résultats Cliniques et Radiologiques du Dispositif de resurfaçage de Hanche ROMAXTM Medacta
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
The goal of this observational study is to collect clinical and radiological data to monitor the safety and performance of the ROMAX hip resurfacing system. The main parameter that will be measured is the rate of revisions at 10 years.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Patients eligible for hip resurfacing, suitable for the implantation of a Medacta ROMAX hip resurfacing system according to the manufacturer's defined indication for use.
• Aged between 18 and 65 years at the time of surgery.
• Ability and willingness to provide written informed consent for participation.
Locations
Other Locations
France
Centre Hospitalier Universitaire de Lille
RECRUITING
Lille
Contact Information
Primary
Marco Viganò, PhD
m.vigano@medacta.ch
+41 0916966060
Time Frame
Start Date: 2025-07-14
Estimated Completion Date: 2037-04-01
Participants
Target number of participants: 150
Treatments
ROMAX
Patients undergoing hip resurfacing surgery with ROMAX system
Related Therapeutic Areas
Sponsors
Leads: Medacta International SA